Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio

Steven Cohen (Trades, Portfolio)'s investment firm, Point72 Asset Management, has recently expanded its investment portfolio by adding shares of Caribou Biosciences Inc (NASDAQ:CRBU). On February 22, 2024, the firm acquired 4,432,602 shares of the biopharmaceutical company, reflecting a significant commitment to the healthcare sector.

Related Keywords

United States , ,Caribou Biosciences Inc Company Overview ,Caribou Biosciences Inc Financial Health ,Guru Holdings ,Bruce Co ,Caribou Biosciences Inc ,Jefferies Group ,Caribou Biosciences Inc Company ,Biosciences Inc ,Caribou Biosciences ,Steven Cohen ,Financial Strength ,Balance Sheet Rank ,Profitability Rank ,Growth Rank ,Point72 Asset Management ,Iopharmaceutical Company ,Investment Portfolio ,Grades ,